---  
layout: startup_page  
title: "Sudo Biosciences"  
id: "sudobio.com"  
permalink: "/sudobiosciencessudobio.com02132024/"  
website: "https://www.sudobio.com"  
funding_round: "Series B"  
funding_amount: "$147M"  
investors: "Enavate Sciences, TPG Life Sciences Innovations, The Rise Fund, Sanofi Ventures, Frazier Life Sciences, Surveyor Capital, Monograph Capital, Eventide Asset Management, Velosity Capital, Dementia Discovery Fund, Leaps by Bayer, UPMC Enterprises"  
about: "Sudo Biosciences is a biopharmaceutical company focused on designing and developing precision TYK2 inhibitors for the treatment of multiple sclerosis, psoriasis, and other autoimmune and neurologic conditions. Their pipeline includes brain-penetrant and topical TYK2 inhibitors, aiming to be first-in-class treatments for various diseases."  
markets: "Biotechnology, Pharmaceuticals, Biopharma, Health Care, Life Science, Medical"  
hq: "Carmel, Indiana, United States"  
founded_year: "2020"  
linkedin: "https://www.linkedin.com/company/sudo-biosciences"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/sudo-biosciences"  
pitchbook: "https://pitchbook.com/profiles/company/509533-03"  

date_display: "13-Feb-2024"  
date: "2024-02-13"

# SEO Optimization  
meta_title: "Sudo Biosciences - Series B Funding ($147M)"  
meta_description: "Sudo Biosciences, Sudo Biosciences is a biopharmaceutical company focused on designing and developing precision TYK2 inhibitors for the treatment of multiple sclerosis,..."  
meta_keywords: "Sudo Biosciences, Biotechnology, Pharmaceuticals, Biopharma, Health Care, Life Science, Medical, Series B funding"  
canonical_url: "https://startup.projectstartups.com/sudobiosciencessudobio.com02132024/"  
---